<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02838303</url>
  </required_header>
  <id_info>
    <org_study_id>12205-01-57-02</org_study_id>
    <nct_id>NCT02838303</nct_id>
  </id_info>
  <brief_title>The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers</brief_title>
  <official_title>The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Augustinus Fonden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate self-reported symptoms as a proxy for acute
      organophosphate poisoning by examining self-reported acute organophosphate poisoning symptoms
      and PchE activity in response to occupational acute organophosphate exposure among farmers in
      Nepal.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in self-reported acute organophosphate poisoning symptoms from baseline to follow up</measure>
    <time_frame>Obtained just before (baseline) and 30 minutes after (baseline) each spray session</time_frame>
    <description>Obtained using a structured questionnaire interview. The definition of symptoms was based on WHO's standardized list of clinical presentations of acute organophosphate poisoning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Plasma Cholinesterase (PchE) activity from baseline to follow up</measure>
    <time_frame>Obtained just before (baseline) and 30 minutes after (baseline) each spray session</time_frame>
    <description>PchE activity was measured with a blood test using a Test-mate Che Cholinesterase System (Model 400) with a PchE Plasma Cholinesterase Assay Kit (Model 470).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Organophosphate Poisoning</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Initial spray session: organophosphate. Crossover spray session: placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Initial spray session: placebo. Crossover spray session: organophosphate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Organophosphate</intervention_name>
    <description>Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Multineem, WHO Class U: Unlikely to present acute hazard in normal use</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <other_name>Biopesticide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male

          -  minimum age 18 years

          -  hand pressured backpack sprayer usage

          -  used to spray with moderately to extremely hazardous pesticides according to the World
             Health Organization's (WHO) Pesticide Hazard Classification

        Exclusion Criteria:

          -  usual personal protective equipment use (respirator/mask with particulate filter, face
             shield, googles, gloves, boots, plastic poncho)

          -  unwilling to stay pesticide-free seven days prior to each of the two spray sessions

          -  medical conditions interfering with PchE activity (liver disease, acute infection,
             chronic malnutrition, heart attack, cancer, obstructive jaundice, inflammation caused
             by various diseases, or use of pyridostigmine drugs)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dea H. Kofod, MB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Occupational and Environmental Medicine, Bispebjerg Frederiksberg Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>July 17, 2016</last_update_submitted>
  <last_update_submitted_qc>July 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Dea Haagensen Kofod</investigator_full_name>
    <investigator_title>MB</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
    <mesh_term>Organophosphate Poisoning</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

